Dataset - CKAN

Comparison of the cytotoxic mechanisms of anti-CD20 monoclonal antibodies Rit...

CD20 is a validated target for the immunotherapy of B lymphoid neoplasms, including ChronicLymphocytic Leukemia (CLL). We compared the activities of rituximab and...
- HTML

You can also access this registry using the API (see API Docs).